BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32686957)

  • 1. Hybrid LC-MS as a powerful tool for supporting protein bioanalysis in gene and cell therapies.
    Wei D; Kim Y; Sugimoto H; Dong L; Qian MG
    Bioanalysis; 2020 Jul; 12(14):977-979. PubMed ID: 32686957
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
    Duggan JX
    Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
    [No Abstract]   [Full Text] [Related]  

  • 3. IQ consortium perspective: complementary LBA and LC-MS in protein therapeutics bioanalysis and biotransformation assessment.
    Kaur S; Bateman KP; Glick J; Jairaj M; F Kellie J; Sydor J; Zeng J
    Bioanalysis; 2020 Feb; 12(4):257-270. PubMed ID: 32096432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supported liquid extraction versus liquid-liquid extraction for sample preparation in LC-MS/MS-based bioanalysis.
    Zhang Y; Cao H; Jiang H
    Bioanalysis; 2013 Feb; 5(3):285-8. PubMed ID: 23394695
    [No Abstract]   [Full Text] [Related]  

  • 5. LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.
    van den Broek I; van Dongen WD
    Bioanalysis; 2015; 7(15):1943-58. PubMed ID: 26295992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix matching in quantitative bioanalysis by LC-MS/MS a dream or a reality?
    Heudi O; Winter S; Picard F
    Bioanalysis; 2020 Jan; 12(2):67-69. PubMed ID: 31854194
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-free workflows for protein quantification by LC-MS/MS.
    Wilffert D; Bischoff R; van de Merbel NC
    Bioanalysis; 2015; 7(6):763-79. PubMed ID: 25871591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.
    Ewles M; Goodwin L
    Bioanalysis; 2011 Jun; 3(12):1379-97. PubMed ID: 21679032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances and strategies towards fully automated sample preparation for regulated LC-MS/MS bioanalysis.
    Zheng N; Jiang H; Zeng J
    Bioanalysis; 2014 Sep; 6(18):2441-59. PubMed ID: 25384595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high-pH (basic/alkaline) mobile phases for LC-MS or LC-MS/MS bioanalysis.
    Tan A; Fanaras JC
    Biomed Chromatogr; 2019 Jan; 33(1):e4409. PubMed ID: 30315658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein quantification using LC-MS: can it make a difference?
    van de Merbel NC; Bronsema KJ; Nemansky M
    Bioanalysis; 2012 Sep; 4(17):2113-6. PubMed ID: 23013393
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving data integrity in regulated bioanalysis: proposal for a generic data transfer process for LC-MS from the European Bioanalysis Forum.
    Arfvidsson C; Bedaf DV; Globig S; Knutsson M; Lewis M; McDougall S; Michi M; Timmerman P
    Bioanalysis; 2020 Jul; 12(14):1033-1038. PubMed ID: 32706625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esterase inhibitors as ester-containing drug stabilizers and their hydrolytic products: potential contributors to the matrix effects on bioanalysis by liquid chromatography/tandem mass spectrometry.
    Zheng N; Fung EN; Buzescu A; Arnold ME; Zeng J
    Rapid Commun Mass Spectrom; 2012 Jun; 26(11):1291-304. PubMed ID: 22555922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do we have a mature LC-MS/MS methodology for therapeutic monoclonal antibody bioanalysis?
    Ismaiel OA; Mylott WR; Jenkins RG
    Bioanalysis; 2017 Sep; 9(17):1289-1292. PubMed ID: 28901174
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulated LC-MS/MS bioanalysis technology for therapeutic antibodies and Fc-fusion proteins using structure-indicated approach.
    Iwamoto N; Shimada T
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):19-24. PubMed ID: 30392772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New opportunities with quantification of protein therapeutics by LC-MS.
    Neubert H; Xu K
    Bioanalysis; 2018 Jul; 10(13):971-973. PubMed ID: 30015519
    [No Abstract]   [Full Text] [Related]  

  • 17. Eliminating Preparation of Multisample External Calibration Curves and Dilution of Study Samples Using the Multiple Isotopologue Reaction Monitoring (MIRM) Technique in Quantitative LC-MS/MS Bioanalysis.
    Gu H; Zhao Y; DeMichele M; Zheng N; Zhang YJ; Pillutla R; Zeng J
    Anal Chem; 2019 Jul; 91(13):8652-8659. PubMed ID: 31180205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays.
    Wang J; Gu H; Liu A; Kozhich A; Rangan V; Myler H; Luo L; Wong R; Sun H; Wang B; Vezina HE; Deshpande S; Zhang Y; Yang Z; Olah TV; Aubry AF; Arnold ME; Pillutla R; DeSilva B
    Bioanalysis; 2016 Jul; 8(13):1383-401. PubMed ID: 27277879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-mass spectrometry applications for quantification of endogenous sex hormones.
    Gravitte A; Archibald T; Cobble A; Kennard B; Brown S
    Biomed Chromatogr; 2021 Jan; 35(1):e5036. PubMed ID: 33226656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of protein therapeutics and biomarkers for LC-MS quantification.
    Pu J; An B; Vazvaei F; Qu J
    Bioanalysis; 2018 Jul; 10(13):979-982. PubMed ID: 29972308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.